FDA — authorised 24 August 2011
- Application: BLA103000
- Marketing authorisation holder: ALLERGAN
- Indication: Efficacy
- Status: approved
FDA authorised Botox on 24 August 2011
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA authorised it on 24 August 2011; FDA has authorised it.
ALLERGAN holds the US marketing authorisation.